{"id":"CHEMBL100116","canonicalSmiles":"CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C","inchiKey":"VOKSWYLNZZRQPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTAZOCINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fortral","Talwin"],"synonyms":["Dl-pentazocine","NIH-7958","NSC-107430","Pentazocine","Pentazocine civ","WIN 20,228","WIN-20228"],"childChemblIds":["CHEMBL3989509","CHEMBL3989510"],"linkedTargets":{"rows":["ENSG00000147955"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for pain and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL101309","canonicalSmiles":"CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1","inchiKey":"PTQXTEKSNBVPQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVASIMIBE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avasimibe","CI-1011"],"crossReferences":{"drugbank":["DB06442"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL105184","canonicalSmiles":"COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)OC)cc(OC)c3c1OCO3)OCO2","inchiKey":"JMZOMFYRADAWOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIFENDATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-ddb","Bifendate","Dimethyl dicarboxylate biphenyl","Diphenyl dimethyl bicarboxylate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL109227","canonicalSmiles":"OB(O)c1ccc(-c2ccc(B(O)O)cc2)cc1","inchiKey":"SLHKDOGTVUCXKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4,4'-Biphenyldiboronic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4,4'-Biphenyldiboronic Acid"],"crossReferences":{"drugbank":["DB02627"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1162483","canonicalSmiles":"CC[C@@H](C)C(=O)O","inchiKey":"WLAMNBDJUVNPJU-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-2-Methylbutanoate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-2-Methylbutanoate"],"crossReferences":{"drugbank":["DB03741"],"chEBI":["45525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1193","canonicalSmiles":"CN(C)CCC(c1ccccc1)c1ccccn1","inchiKey":"IJHNSHDBIRRJRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENIRAMINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-47965","Pheniramine","Propheniramine","Prophenpyridamine","Pyriton","Tripoton"],"crossReferences":{"DailyMed":["pheniramine%20maleate"],"PubChem":["90341510"],"Wikipedia":["Pheniramine"],"drugbank":["DB01620"]},"childChemblIds":["CHEMBL1596440","CHEMBL1580221","CHEMBL1653"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0005271","EFO_0007328","EFO_0007141","EFO_0007214","MONDO_0024355"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for allergic disease and pruritus and has 3 investigational indications."}
{"id":"CHEMBL1198148","canonicalSmiles":"CC[C@@H](N)C(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=N)N)cc1","inchiKey":"YHAMQFKGUUSJMU-KGLIPLIRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198148","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06947"]},"childChemblIds":["CHEMBL597202","CHEMBL3423206"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200321","canonicalSmiles":"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C.OCCNCCO","inchiKey":"FEPTXVIRMZIGFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFISOXAZOLE DIOLAMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL453","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gantrisin","Sulfisoxazole diolamine"],"synonyms":["NU-445","Sulfafurazole diethanolamine","Sulfafurazole diolamine","Sulfisoxazole diolamine","Sulphafurazole diolamine"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200348","canonicalSmiles":"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O","inchiKey":"CRKGMGQUHDNAPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULCONAZOLE NITRATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1221","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exelderm"],"synonyms":["NSC-757849","RS-44872","RS-44872-00-10-3","RS-44872-00-1O-3","Sulconazole nitrate","Sulcosyn"],"crossReferences":{"DailyMed":["sulconazole%20nitrate"],"PubChem":["144204222","170465344","26748515","26748516","50107420","50107421","56422432","855903"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for tinea pedis."}
{"id":"CHEMBL1200485","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"IVDHYUQIDRJSTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORAFENIB TOSYLATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1336","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nexavar"],"synonyms":["BAY 54-9085","BAY-54-9085","Sorafenib tosilate","Sorafenib tosylate"],"crossReferences":{"DailyMed":["sorafenib%20tosylate"],"PubChem":["144206042","170465175","85147444"],"chEBI":["50928"]},"linkedTargets":{"rows":["ENSG00000128052","ENSG00000165731","ENSG00000102755","ENSG00000037280","ENSG00000157764","ENSG00000157404","ENSG00000113721","ENSG00000132155","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0000637","EFO_0000365","EFO_0000756","EFO_0000681","EFO_1000657","EFO_1001052","EFO_1001951","EFO_0000588","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0000501","EFO_0000641","EFO_0002618","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0009907","EFO_1001968","MONDO_0004986","EFO_0000224","MONDO_0008315","EFO_1001967","MONDO_0002691","MONDO_0044787","EFO_0003032","MONDO_0000544","EFO_0000335","EFO_1000613","EFO_0001378","MONDO_0021640","EFO_0002938","MONDO_0004192","EFO_1001465","MONDO_0007254","EFO_0003871","EFO_1001469","MONDO_0021063","MONDO_0002087","MONDO_0044937","MONDO_0020654","MONDO_0001187","EFO_1000044","MONDO_0002158","EFO_0006352","EFO_0000673","EFO_0002499","MONDO_0020743","EFO_1000158","EFO_0002914","EFO_0000616","MONDO_0019457","Orphanet_44890","EFO_0000403","EFO_0000222","EFO_0002501","EFO_0007535","MONDO_0021038","EFO_0003060","EFO_0000311","EFO_0000640","EFO_0006861","EFO_0000095","EFO_0002892","EFO_0000702","MONDO_0017386","MONDO_0002367","MONDO_0024880","EFO_0003833","EFO_0000691","EFO_0000519","MONDO_0044926"],"count":73},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 7 approved and 54 investigational indications."}
{"id":"CHEMBL1200660","canonicalSmiles":"O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12","inchiKey":"KLDXJTOLSGUMSJ-JGWLITMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOSORBIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ismotic"],"synonyms":["1,4:3,6-dianhydro-d-glucitol","AT-101","D-glucitol, 1,4:3,6-dianhydro-","Isobide","Isosorbide","NSC-40725"],"crossReferences":{"PubChem":["170465187","29216190","29218044","29218045"],"Wikipedia":["Isosorbide"],"drugbank":["DB09401"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 12 investigational indications."}
{"id":"CHEMBL1200756","canonicalSmiles":"Cc1ncc(CO)c(CO)c1O.Cl","inchiKey":"ZUFQODAHGAHPFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1364","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beesix","Benadon","Comploment continus","Hexa-betalin","Kent b6","Lyphomed","Orovite comploment b6","Pyrid-10","Pyrid-20","Pyridox hcl","Pyridox-roche","Pyridoxine hydrochloride","Pyridoxol Hcl","Vital foods","Vitalife","Vitamin B6"],"synonyms":["NSC-36225","Pyridoxine chloride","Pyridoxine hcl","Pyridoxine hydrochloride","Pyridoxini hydrochloridum","Pyridoxinum hydrochloricum","Pyridoxol hydrochloride","Vitamin b6","Vitamin b6 hydrochloride"],"crossReferences":{"DailyMed":["pyridoxine%20hydrochloride"],"PubChem":["144212793","26757736","51085174"],"chEBI":["30961"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1200774","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](C[C@H](F)C4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"MYYIMZRZXIQBGI-HVIRSNARSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPREDNISOLONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphadrol"],"synonyms":["Fluprednisolone","NSC-47439","U-7800"],"crossReferences":{"PubChem":["144205251","144206694","170465086"],"Wikipedia":["Fluprednisolone"],"drugbank":["DB09378"],"chEBI":["34474"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200795","canonicalSmiles":"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"PMGQWSIVQFOFOQ-YKVZVUFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEMASTINE FUMARATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1626","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clemastine fumarate","Tavegil","Tavist","Tavist-1"],"synonyms":["Clemastine fumarate","Clemastine hydrogen fumarate"],"crossReferences":{"DailyMed":["clemastine%20fumarate"],"PubChem":["144204125","170465318","93576607"],"chEBI":["3739"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0005531","MONDO_0005301","MONDO_0005271","EFO_0007214","EFO_0003956"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL1201035","canonicalSmiles":"Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2","inchiKey":"RDNLAULGBSQZMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIPERIDEN HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1101","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akineton","Akineton ret"],"synonyms":["Akinophyl","Biperiden hcl","Biperiden hydrochloride","Biperideni hydrochloridum","NSC-170950","NSC-84989","Tasmolin"],"crossReferences":{"PubChem":["144206338","144206615","170465324"],"chEBI":["59171"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959."}
{"id":"CHEMBL1201171","canonicalSmiles":"CCCCOc1ccc(OCCCN2CCOCC2)cc1.Cl","inchiKey":"SYCBXBCPLUFJID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMOXINE HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1198","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tronolane","Tronothane"],"synonyms":["NSC-25573","Pramocaine hydrochloride","Pramoxine hcl","Pramoxine hydrochloride"],"crossReferences":{"DailyMed":["pramoxine%20hydrochloride"],"PubChem":["144204028","170465004","26748507","855556"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 5 approved indications."}
{"id":"CHEMBL1201177","canonicalSmiles":"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl","inchiKey":"DNTDOBSIBZKFCP-YDALLXLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBUNOLOL HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201237","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akbeta","Betagan","Levobunolol hydrochloride"],"synonyms":["Levobunolol hcl","Levobunolol hydrochloride","NSC-759158","W 7000A","W-7000A"],"crossReferences":{"DailyMed":["levobunolol%20hydrochloride"],"PubChem":["144204168","170464743","56463666"],"chEBI":["6439"]},"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for glaucoma."}
{"id":"CHEMBL1201347","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1","inchiKey":"LKYQLAWMNBFNJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANILERIDINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Adopol","Alidine","Anileridine","Apidol","IDS-NA-012","Leritin","Nipecotan"],"crossReferences":{"PubChem":["170465266"],"Wikipedia":["Anileridine"],"drugbank":["DB00913"],"chEBI":["61203"]},"childChemblIds":["CHEMBL1200543","CHEMBL1201047"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201764","canonicalSmiles":"CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1","inchiKey":"DCCSDBARQIPTGU-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FESOTERODINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fesoterodine"],"crossReferences":{"DailyMed":["fesoterodine%20fumarate"],"Wikipedia":["Fesoterodine"],"drugbank":["DB06702"]},"childChemblIds":["CHEMBL1201765"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0006865","HP_0000020","EFO_1001762","EFO_0000673","EFO_1000781","HP_0000011","HP_0000103"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL1201786","canonicalSmiles":"CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1","inchiKey":"UGJWZYARKOFRDB-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"LAPYRIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lapyrium","Lapyrium cation","Lapyrium ion"],"crossReferences":{"Wikipedia":["Lapyrium"],"drugbank":["DB09376"]},"childChemblIds":["CHEMBL1201787"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1233860","canonicalSmiles":"CSCCC(=O)C(=O)O","inchiKey":"SXFSQZDSUWACKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233860","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02238"],"chEBI":["33574"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234751","canonicalSmiles":"CC(=O)N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"RFMMMVDNIPUKGG-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLGLUTAMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205861","170466605","29217838"],"drugbank":["DB04075"],"chEBI":["17533"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236446","canonicalSmiles":"CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](CC(=O)NO)CO[C@H](CO)[C@H]1O","inchiKey":"INAPDIIIYSWKOC-XHIHJMKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236446","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1328968","canonicalSmiles":"C=C1C[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O","inchiKey":"UDKABVSQKJNZBH-DWNQPYOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELENGESTROL ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5373","BDH 1921","BDH-1921","Melengesterol","Melengestrel","Melengestrol","Melengestrol acetate","NSC-70968"],"crossReferences":{"PubChem":["144205440","144213722","170465702","29218056","56323955"],"drugbank":["DB14659"],"chEBI":["34831"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1330588","canonicalSmiles":"Cc1cc(=O)[nH]c(=S)[nH]1","inchiKey":"HWGBHCRJGXAGEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLTHIOURACIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylthiouracil","NSC-193526","Thimecil"],"crossReferences":{"PubChem":["144204639","144209068","144210815","170466508","17389816","26747305","8139888","85272317"],"drugbank":["DB13644"],"chEBI":["82346"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1355596","canonicalSmiles":"CCCCCCOc1ccc(C(=N)N(CCCC)CCCC)c2ccccc12","inchiKey":"FGGFIMIICGZCCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUNAMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bunamidine"],"crossReferences":{"PubChem":["50125801"],"drugbank":["DB11501"]},"childChemblIds":["CHEMBL2104240"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL142936","canonicalSmiles":"CCN(CC)CCc1c[nH]c2ccccc12","inchiKey":"LSSUMOWDTKZHHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLTRYPTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N,N-Diethyltryptamine"],"crossReferences":{"PubChem":["124954093"],"Wikipedia":["Diethyltryptamine"],"drugbank":["DB01460"]},"childChemblIds":["CHEMBL3184651"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1432","canonicalSmiles":"O=C(O)c1cccc(O)c1O","inchiKey":"GLDQAMYCGOIJDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-DIHYDROXYBENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-Dihydroxybenzoic Acid","2,3-Dihydroxybenzoicacid"],"crossReferences":{"PubChem":["47193697"],"Wikipedia":["2,3-Dihydroxybenzoic_acid"],"drugbank":["DB01672"],"chEBI":["18026"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1509","canonicalSmiles":"C[C@]12CC[C@H]3[C@H]([C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1)[C@H]1C[C@H]1C1=CC(=O)CC[C@@]13C","inchiKey":"METQSPRSQINEEU-HXCATZOESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROSPIRENONE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Angeliq","Slynd"],"synonyms":["Drospirenone","NSC-760103","ZK 30595","ZK-30595"],"crossReferences":{"DailyMed":["drospirenone"],"PubChem":["144205769","170464870"],"Wikipedia":["Drospirenone"],"drugbank":["DB01395"],"chEBI":["50838"]},"linkedTargets":{"rows":["ENSG00000082175","ENSG00000151623"],"count":2},"linkedDiseases":{"rows":["EFO_0005204","MONDO_0002050","EFO_1000710","MONDO_0004169","EFO_0009006","HP_0100607","EFO_0000319","EFO_0010270","EFO_0003894","EFO_0003843","EFO_0000660","EFO_0000537","EFO_0005924"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for acne and has 7 investigational indications."}
{"id":"CHEMBL156791","canonicalSmiles":"CC(C)(C)NCC(O)COc1cc(Cl)ccc1Cl","inchiKey":"XYCMOTOFHFTUIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORANOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chloranolol","Cloranolol","Tobanum"],"crossReferences":{"drugbank":["DB13508"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1608183","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"ZOCUOMKMBMEYQV-GSLJADNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOFLUPREDONE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".delta.-fluorocortisone","9-fluoroprednisolone","Isoflupredone","Isoflupredone 21-acetate","Isoflupredone acetate","NSC-12174","NSC-12600","NSC-37977","U-6013"],"crossReferences":{"PubChem":["144203988","170465628","56463338","77262","94137"],"drugbank":["DB14640"],"chEBI":["34517"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1650","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C","inchiKey":"ITRJWOMZKQRYTA-RFZYENFJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORTISONE ACETATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cortate","Cortelan","Cortisone acetate","Cortistab","Cortisyl","Cortone"],"synonyms":["Cortisone","Cortisone 21-acetate","Cortisone Acetate","Cortisone acetate","Cortisone aceticum","NSC-49420"],"crossReferences":{"DailyMed":["cortisone%20acetate"],"PubChem":["144207031","170464685","29214995","50103888","855514","90341460"],"drugbank":["DB01380"],"chEBI":["3897"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0009491","EFO_1001896","EFO_1001205","EFO_0005319","EFO_1000997","EFO_1000764","EFO_0004274","EFO_1001435","HP_0001094","MONDO_0005271","EFO_0003778","EFO_1000684","EFO_0000274","HP_0001915","EFO_0005558","EFO_0008997","EFO_0000565","HP_0004398","EFO_0007160","EFO_0009456","EFO_1000694","EFO_0002690","EFO_0004255","EFO_0003063","EFO_0004276","EFO_0005752","EFO_1001250","HP_0003072","MONDO_0043579","EFO_0000685","MONDO_0015128","EFO_1000039","EFO_0005532","HP_0001873","EFO_1000941","EFO_1001119","Orphanet_418","EFO_0002609","EFO_0003106","Orphanet_90794","EFO_1000049","EFO_0007403","EFO_0000398","EFO_0000574","EFO_1001194","MONDO_0004979","MONDO_0005178"],"count":47},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 44 approved and 2 investigational indications."}
{"id":"CHEMBL1663","canonicalSmiles":"FC(F)(F)C(F)(F)C(F)(F)F","inchiKey":"QYSGYZVSCZSLHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERFLUTREN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Definity","Definity rt"],"synonyms":["DMP 115","DMP-115","FS-069","FS069","MRX-115","Perfluoropropane","Perflutren"],"crossReferences":{"DailyMed":["perflutren"],"Wikipedia":["Octafluoropropane"],"drugbank":["DB00556"],"chEBI":["31980"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1697843","canonicalSmiles":"CO[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@@H]1C","inchiKey":"IYJMSDVSVHDVGT-PEQKVOOWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METILDIGOXIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lanitop"],"synonyms":[".beta.-methyldigoxin","4'''-.beta.-methyldigoxin","4'''-o-methyldigoxin","Digoxin, 4'''-o-methyl-","Lanirapid","Medigoxin","Methyldigoxin","Methyldigoxin, beta","Metildigoxin"],"crossReferences":{"PubChem":["144206178"],"drugbank":["DB13401"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL1716983","canonicalSmiles":"C[n+]1ccc(C(=O)NCc2ccccc2)cc1.[I-]","inchiKey":"ILSOAHPXYZRFBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENISAMIUM IODIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1740071","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbabenzpyride","Enisamium iodide"],"crossReferences":{"PubChem":["47202951"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743029","drugType":"Antibody","blackBoxWarning":false,"name":"IBALIZUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trogarzo"],"synonyms":["HU5A8","Ibalizumab","Ibalizumab-uiyk","TNX-355"],"crossReferences":{"DailyMed":["ibalizumab-uiyk"]},"linkedTargets":{"rows":["ENSG00000010610"],"count":1},"linkedDiseases":{"rows":["EFO_0000544","EFO_0000764","EFO_0000180","EFO_0000763"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1766417","canonicalSmiles":"CNC(=O)C[C@@H]1NC(=O)c2csc(n2)-c2ccc(-c3nc(C4=N[C@H](C(=O)N5CCC[C@H]5C(N)=O)CO4)cs3)nc2-c2csc(n2)-c2csc(n2)[C@H]([C@@H](O)c2ccccc2)NC(=O)CNC(=O)c2nc(sc2COC)[C@H](C(C)C)NC(=O)c2nc1sc2C","inchiKey":"JMDULECOHIXMNX-MZHFYNGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1766417","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02975"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL185","canonicalSmiles":"O=c1[nH]cc(F)c(=O)[nH]1","inchiKey":"GHASVSINZRGABV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOROURACIL","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["5.f.u.","Accusite","Actikerall","Adrucil","Carac","Efudex","Efudix","Fluoro-uracil roche","Fluoroplex","Fluorouracil","Tolak"],"synonyms":["5 FU","5-FU","5-Fluorouracil","5-fluoruracil","Fluorouracil","Fluorouracilum","Fluorouricil","Fluracil","NSC-19893","Phthoruracil","Queroplex","RO 2-9757","RO-2-9757","RO-29757"],"crossReferences":{"DailyMed":["fluorouracil"],"PubChem":["104171158","11111190","124880118","124880121","144203701","144209533","144210432","170464762","17389875","174007005","26747342","26752979","50105574","8139872","82653","85231050","90341469"],"Wikipedia":["Fluorouracil"],"drugbank":["DB00544"],"chEBI":["46345"]},"linkedTargets":{"rows":["ENSG00000176890"],"count":1},"linkedDiseases":{"rows":["EFO_1000256","EFO_1000910","EFO_0004190","EFO_0000365","EFO_0003859","EFO_0000756","EFO_0000681","EFO_0005952","EFO_1001129","MONDO_0044704","EFO_1000984","EFO_1001951","EFO_0000178","MONDO_0002974","EFO_1000251","EFO_0008528","EFO_1000532","EFO_0004606","EFO_1000028","MONDO_0002038","EFO_0004288","MONDO_0056819","EFO_1001949","EFO_0000198","EFO_0002618","EFO_0005922","EFO_0007363","EFO_0000402","MONDO_0004986","EFO_0005221","EFO_0002496","MONDO_0001879","MONDO_0002691","EFO_0000546","EFO_1001365","EFO_0000678","MONDO_0000831","EFO_0009259","EFO_1000527","EFO_0004284","EFO_0000574","EFO_0001378","EFO_0000516","MONDO_0002516","EFO_0005577","EFO_0007416","MONDO_0007254","EFO_0004252","MONDO_0044937","MONDO_0020654","EFO_0003817","MONDO_0001056","EFO_0003100","EFO_0000326","EFO_0004193","EFO_0000707","EFO_0005588","Orphanet_144","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","Orphanet_44890","MONDO_0007576","EFO_1001961","EFO_1001471","MONDO_0002120","EFO_0008549","EFO_0002517","EFO_0000199","MONDO_0002367","MONDO_0024880","MONDO_0024475","MONDO_0003060","EFO_0003869","EFO_0001075","EFO_1002023","EFO_1000657","EFO_0000228","MONDO_0003212","MONDO_0002358","EFO_0006732","EFO_0000389","EFO_0000182","EFO_1000720","MONDO_0003199","EFO_0004208","EFO_0000364","EFO_1000166","EFO_1000606","EFO_0000197","EFO_1000292","EFO_0000698","MONDO_0021321","MONDO_0008170","EFO_0005842","EFO_0000504","EFO_0009708","EFO_0000294","EFO_1001100","EFO_0002428","EFO_0006544","EFO_0003835","MONDO_0021355","EFO_1000172","EFO_0002938","EFO_1001901","MONDO_0004192","MONDO_0015686","EFO_0003866","EFO_0005950","MONDO_0021063","MONDO_0002087","EFO_0000305","MONDO_0020657","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000218","EFO_0003860","EFO_0004212","EFO_0002617","EFO_0000503","EFO_0000478","EFO_0000313","EFO_0003060","EFO_0000311","EFO_0005570","MONDO_0003572","EFO_0010282","EFO_0004142","MONDO_0003219","EFO_1000081","EFO_0000181"],"count":134},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and has 6 approved and 96 investigational indications."}
{"id":"CHEMBL194859","canonicalSmiles":"O=C(c1ccc(O)cc1)c1ccc(O)cc1","inchiKey":"RXNYJUSEXLAVNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4,4'-Dihydroxybenzophenone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4,4'-Dihydroxybenzophenone","4,4-Dihydroxybenzophenone"],"crossReferences":{"PubChem":["144207748"],"Wikipedia":["4,4%27-Dihydroxybenzophenone"],"drugbank":["DB07635"],"chEBI":["34365"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1967878","canonicalSmiles":"Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1","inchiKey":"KSOVGRCOLZZTPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENISERTIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS 703569","AS-703569","AS703569","As-703569","As703569","Aurora kinase inhibitor as703569","Cenisertib","R 763","R-763"],"crossReferences":{"PubChem":["103904402","103904437"]},"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001642"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL202609","canonicalSmiles":"CC[C@@H](Cc1ccc(OC)c(CNC(=O)c2ccc(C(F)(F)F)cc2F)c1)C(=O)O","inchiKey":"BDLLIPYDNFENMY-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202609","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07070"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096655","drugType":"Small molecule","blackBoxWarning":false,"name":"CYANOCOBALAMIN CO 57","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110563","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Racobalamin-57","Rubratope-57"],"synonyms":["(57co)vitamin b12","57co","Cobalt (57co) cyanocobalamin","Cobalt (57co) cyanocobalamine","Cyanocobalamin (57 co)","Cyanocobalamin (57co)","Cyanocobalamin co 57","Cyanocobalamin co-57","Cyanocobalamin co57","Cyanocobalamin, co-57","Cyanocobalamin,co-57","Radioactive 57co vitamin b12","Vitamin b12, co-57"],"crossReferences":{"DrugCentral":["4847"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2103778","canonicalSmiles":"Cc1nccn1C[C@H]1CCc2c(c3cccc4c3n2CCC4)C1=O","inchiKey":"NCNFDKWULDWJDS-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILANSETRON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilansetron","KC-9946"],"crossReferences":{"drugbank":["DB04885"]},"childChemblIds":["CHEMBL2107807"],"linkedTargets":{"rows":["ENSG00000149305","ENSG00000166736"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104136","canonicalSmiles":"CN(C)CCCC1c2ccccc2Nc2ccc(Cl)cc21.O=P(O)(O)O","inchiKey":"SKKDWRIEPIZVOR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMACRAN PHOSPHATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1615350","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hepatotoxicity"],"year":1982},"tradeNames":["Devryl","Olaxin"],"synonyms":["Clomacran phosphate","SK&F 14336","SKF-14336"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom  in 1982 due to Hepatotoxicity."}
{"id":"CHEMBL2104688","canonicalSmiles":"CCCN(CCC)C(=O)C(Cc1ccc(OCCN(CC)CC)cc1)NC(=O)c1ccccc1","inchiKey":"FDBWMYOFXWMGEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIROPRAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tiropramide"],"crossReferences":{"drugbank":["DB13091"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105505","canonicalSmiles":"Cc1ccccc1C(O)(c1ccccc1C)C1CN2CCC1CC2","inchiKey":"OXDOWGVJMITMJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEQUIFENADINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sequifenadine"],"crossReferences":{"drugbank":["DB13566"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105890","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)C(=O)[C@]1(C)OC.O=C(O)/C=C/C(=O)O","inchiKey":"IDLXWTNPDREJQZ-HSOMBQIOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITEMCINAL FUMARATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110756","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["115-8543 JAPAN","115-8543-JAPAN","5-1 UKIMA 5 CHOME","5-1-UKIMA-5-CHOME","GM-611","KITA-KU TOYKO","Mitemcinal fumarate"],"linkedTargets":{"rows":["ENSG00000102539"],"count":1},"linkedDiseases":{"rows":["EFO_1000948"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105983","canonicalSmiles":"Nc1ccc(C(=O)[O-])c(O)c1.Nc1ccc(C(=O)[O-])c(O)c1.[Ca+2]","inchiKey":"XDWVNCOPMIEDJK-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOSALICYLATE CALCIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1169","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminosalicylate calcium","Calcium aminosalicylate","Calcium para-aminosalicylate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106499","canonicalSmiles":"CC(C)[C@H](N)C(=O)O[C@@H]1C[C@@H](n2ccc(N)nc2=O)O[C@H]1CO","inchiKey":"VFCYZPOEGWLYRM-QCZKYFFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALTORCITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'-val-l-dc","Valtorcitabine","Valtorcitabine dihydrochloride"],"crossReferences":{"drugbank":["DB06187"]},"childChemblIds":["CHEMBL2107810"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106763","canonicalSmiles":"C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"YVHXHNGGPURVOS-SBTDHBFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPREDNIDENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluprednidene"],"crossReferences":{"drugbank":["DB08970"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107383","canonicalSmiles":"COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC.Cl","inchiKey":"JMHYCBFEEFHTMK-IIUXMCBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERNAKALANT HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111112","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brinavess","Kynapid","RSD-1235","RSD1235","Vernakalant hcl","Vernakalant hydrochloride"],"linkedTargets":{"rows":["ENSG00000183873","ENSG00000055118","ENSG00000162989","ENSG00000130037","ENSG00000120457","ENSG00000171385"],"count":6},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107525","canonicalSmiles":"O=[32P]([O-])([O-])O.[Na+].[Na+]","inchiKey":"BNIILDVGGAEEIG-JCIGTKTHSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PHOSPHATE P 32","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1060","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Phosphotope","Sodium phosphate p 32"],"synonyms":["32p","Sodium phosphate (32 p)","Sodium phosphate (32p)","Sodium phosphate p 32","Sodium phosphate p-32","Sodium phosphate p32","Sodium phosphate, p-32","Sodium phosphate,p-32"],"crossReferences":{"DrugCentral":["5036"],"drugbank":["DB09370"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957."}
{"id":"CHEMBL2108442","drugType":"Antibody","blackBoxWarning":false,"name":"MITUMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BEC2","Mitumomab"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108653","drugType":"Protein","blackBoxWarning":false,"name":"THROMBOMODULIN ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Recomodulin (japan only)"],"synonyms":["ART-123","Recomodulin","Thrombomodulin alfa","Thrombomodulin alfa (genetical recombination)"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108673","drugType":"Antibody","blackBoxWarning":false,"name":"VORSETUZUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sgn-70, h1f6"],"synonyms":["H-1F6","SGN-70","Vorsetuzumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109364","drugType":"Antibody","blackBoxWarning":false,"name":"AR-20.5","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-20.5"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109522","drugType":"Antibody","blackBoxWarning":false,"name":"PF-03446879","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03446879"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109598","drugType":"Antibody","blackBoxWarning":false,"name":"BIIB-023","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-023","Biib-023"],"linkedTargets":{"rows":["ENSG00000239697"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005761"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2110577","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2OC(C)=O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"CVBHEIRZLPKMSH-SNWVVRALSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN ACISTRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Erasis"],"synonyms":["Erythromycin","Erythromycin acistrate"],"childChemblIds":["CHEMBL1908310"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL220492","canonicalSmiles":"CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1","inchiKey":"KJADKKWYZYXHBB-XBWDGYHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOPIRAMATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"crossReferences":{"DailyMed":["topiramate"],"PubChem":["144205025","144212718","170464746"],"Wikipedia":["Topiramate"],"drugbank":["DB00273"],"chEBI":["63631"]},"linkedTargets":{"rows":["ENSG00000167434","ENSG00000125675","ENSG00000145863","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000149403","ENSG00000152578","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000022355","ENSG00000183873","ENSG00000104267","ENSG00000155511","ENSG00000186297","ENSG00000153253","ENSG00000163288","ENSG00000136546","ENSG00000120251","ENSG00000109158","ENSG00000168356","ENSG00000166206","ENSG00000163873","ENSG00000182256","ENSG00000102287","ENSG00000164418","ENSG00000144285","ENSG00000171189","ENSG00000094755","ENSG00000169432","ENSG00000163285","ENSG00000105737","ENSG00000268089","ENSG00000113327","ENSG00000136531"],"count":37},"linkedDiseases":{"rows":["EFO_0005204","MONDO_0005090","EFO_0002610","HP_0000726","HP_0001268","EFO_0003768","EFO_1001917","HP_0011868","EFO_0005924","EFO_0007191","MONDO_0002046","MONDO_0005277","HP_0100543","EFO_0004211","EFO_0000474","EFO_0000289","Orphanet_739","MONDO_0002050","EFO_0004263","MONDO_0005180","MONDO_0005299","EFO_1000632","HP_0002013","EFO_0004701","MONDO_0007079","EFO_0004242","EFO_0005230","EFO_0000400","EFO_0004319","HP_0000360","EFO_0005203","EFO_0004329","EFO_0005207","EFO_0001358","HP_0001250","Orphanet_2382","EFO_0010445","EFO_0001073","EFO_0003843","HP_0002315","EFO_0000537","EFO_0000195","MONDO_0005301","MONDO_0021187","EFO_0004895","EFO_0001421","EFO_0004699","EFO_0000516","EFO_0007262","EFO_0004270","MONDO_0005148","EFO_0003108"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 approved and 40 investigational indications."}
{"id":"CHEMBL2218908","canonicalSmiles":"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"ZESIAEVDVPWEKB-ORCFLVBFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"COLISTIN SULFATE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2221249","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cantrex","Coly-mycin","Coly-mycin s","Kanamycin","Kanamycin Sulfate","Kannasyn","Kantrex","Kantrim","Klebcil"],"synonyms":["Belcomycin","Belcomycine","Colimycin sulfate","Colimycin sulphate","Colistin sulfate","Colistin sulphate","Colistins sulfate","Colistins sulphate","NSC-759273","Polymixin e sulfate","Polymixin e sulphate"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL227439","canonicalSmiles":"O=C(COc1ccc(Cl)cc1)Nc1ccccc1C(=O)O","inchiKey":"LXSDGQYDSDIUPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227439","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07185"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228077","canonicalSmiles":"NC(=O)[C@@H]1C[C@@H](NC(=O)[C@@H](N)CCC/N=C(\\N)N[N+](=O)[O-])CN1","inchiKey":"IUFRDGFKAVLPFZ-CSMHCCOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL228077","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02077"]},"childChemblIds":["CHEMBL161297"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2287680","canonicalSmiles":"O=C(NC(=O)c1c(F)cccc1F)Nc1ccc(Oc2ccc(C(F)(F)F)cc2Cl)cc1F","inchiKey":"RYLHNOVXKPXDIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUFENOXURON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211081"],"drugbank":["DB15006"],"chEBI":["39382"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2366023","canonicalSmiles":"CCCCCCCC[N+](C)(C)CCCCCCCC","inchiKey":"MELGLHXCBHKVJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2366023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["225144332"],"drugbank":["DB13970"]},"childChemblIds":["CHEMBL2357351"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2375161","canonicalSmiles":"CCCCCc1ccc(/C(C)=C/C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]2C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c3ccccc3N)C(=O)O[C@@H]2C)cc1","inchiKey":"DYNMYYRPPFVAKR-ZXTAUSOFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SUROTOMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cb-183, 315"],"synonyms":["CB-183,315","CB-183315","Surotomycin"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL25","canonicalSmiles":"CC(=O)Oc1ccccc1C(=O)O","inchiKey":"BSYNRYMUTXBXSQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPIRIN","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["8-hour bayer","Acetosalic Acid","Acetylsalic acid","Acetylsalicylic Acid","Alka rapid","Anadin all night","Angettes 75","Aspirin","Aspro clr","Bayer extra strength aspirin for migraine pain","Danamep","Disprin cv","Disprin direct","Durlaza","Ecotrin","Enprin","Equi-Prin","Gencardia","Levius","Max strgh aspro clr","Measurin","Micropirin ec","Nu-seals 300","Nu-seals 600","Nu-seals 75","Nu-seals cardio 75","Paynocil","Platet","Platet 300","Postmi 300","Postmi 75","Salicylic Acid Acetate","Vazalore"],"synonyms":["Acetyl salicylate","Acetylsalicylic Acid","Acetylsalicylic acid","Acetylsalicylic acid (who-ip)","Acetylsalicylicum acidum","Acidum acetylsalicylicum","Aspirin","BAY1019036","Benzoic acid, 2-(acetyloxy)-","NSC-27223","NSC-406186"],"crossReferences":{"DailyMed":["aspirin"],"PubChem":["144203627","144209315","144210466","170465039","17389202","17390036","174007205","26747283","26752858","47193676","50105490","85230910","87798","90340586"],"TG-GATEs":["14"],"Wikipedia":["Aspirin"],"drugbank":["DB00945"],"chEBI":["15365"]},"childChemblIds":["CHEMBL1697753","CHEMBL2296002"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["Orphanet_64739","EFO_0001361","EFO_0000275","EFO_0000401","EFO_0003768","EFO_0003762","HP_0012228","EFO_0004698","EFO_1001923","EFO_1001951","EFO_0003914","EFO_0003931","EFO_0000339","EFO_0008585","EFO_0002690","MONDO_0002974","EFO_0009573","EFO_0003884","EFO_1000882","EFO_0000400","EFO_1000059","MONDO_0002635","EFO_0009686","HP_0005521","EFO_0010072","EFO_0004286","EFO_0007443","EFO_0000180","EFO_0004607","MONDO_0008315","EFO_0001663","EFO_1002022","EFO_0000546","MP_0001914","GO_0007568","MONDO_0000831","MONDO_0004979","HP_0100607","EFO_0001378","EFO_0000341","EFO_0003907","EFO_0007328","MONDO_0002258","EFO_1000860","EFO_0005672","EFO_0004610","MONDO_0021108","MONDO_0007254","MONDO_0043839","EFO_0004252","EFO_1000637","EFO_0000495","EFO_0009606","MONDO_0001056","EFO_0000289","EFO_0009854","EFO_0003763","HP_0004419","EFO_1001161","EFO_0000707","Orphanet_144","EFO_0000694","EFO_0000280","EFO_0000616","EFO_0006859","HP_0020174","EFO_0001645","EFO_1001157","MONDO_0007576","EFO_0005407","EFO_0000319","HP_0003418","GO_0070527","EFO_0003929","EFO_0009463","EFO_0009315","EFO_0003843","HP_0002315","EFO_0000537","EFO_1000954","EFO_0000195","EFO_0009454","EFO_1000881","MONDO_0010888","MONDO_0021661","EFO_0000649","EFO_0000764","MONDO_0011962","EFO_0009314","MONDO_0005148","EFO_0005411","EFO_0000519","EFO_0010820","EFO_0004265","MONDO_0005178","EFO_0004264","EFO_0008493","EFO_0000729","EFO_0003869","EFO_0003777","HP_0002745","HP_0002239","MONDO_0041052","MONDO_0002009","EFO_0000571","EFO_0005406","EFO_1000657","EFO_1001154","EFO_0000266","MONDO_0000527","EFO_0003913","EFO_0003870","Orphanet_733","EFO_0000389","EFO_0000182","HP_0003419","EFO_0007541","HP_0012378","EFO_0003893","HP_0003124","EFO_0005856","MONDO_0008170","Orphanet_3389","EFO_0002429","Orphanet_309005","EFO_0000294","HP_0100806","HP_0003326","MP_0001845","MONDO_0100096","EFO_0009659","EFO_0000668","MONDO_0005090","Orphanet_232","MONDO_0002679","EFO_0009846","EFO_1000883","MONDO_0021063","EFO_0000538","EFO_0002950","EFO_0004246","HP_0004398","MONDO_0005277","EFO_0004211","EFO_0004247","EFO_1001375","EFO_0003144","EFO_0000712","EFO_0020925","MONDO_0005129","MONDO_0004247","EFO_0000673","HP_0000618","EFO_0007427","EFO_0007129","EFO_0000717","HP_0004936","EFO_0008586","EFO_0000479","HP_0002140","EFO_0000545","EFO_0003875","HP_0001945","HP_0001655","EFO_0000556","EFO_0003770","EFO_0004277","HP_0003394","EFO_0003060","EFO_0007214","EFO_0002615","EFO_0000311","EFO_0003106","EFO_0010282","EFO_0003764","EFO_0009364","MONDO_0005147","EFO_0008583","EFO_0000612","EFO_0005611","EFO_0004259"],"count":181},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 19 approved and 134 investigational indications."}
{"id":"CHEMBL264374","canonicalSmiles":"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O","inchiKey":"IIBYAHWJQTYFKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEZAFIBRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bezagen xl","Bezalip","Bezalip-mono","Fibrazate xl","Liparol xl","Zimbacol xl"],"synonyms":["BM 15.075","BM-15.075","BM-15075","Bezafibrate","Bezatol sr","NSC-758174"],"crossReferences":{"PubChem":["11112764","144204196","144212162","170465743","26751546","26751547","56422496","855877","90341401"],"Wikipedia":["Bezafibrate"],"drugbank":["DB01393"],"chEBI":["47612"]},"linkedTargets":{"rows":["ENSG00000112033","ENSG00000186951","ENSG00000132170"],"count":3},"linkedDiseases":{"rows":["EFO_0000198","Orphanet_68380","EFO_0000289","EFO_0004268","Orphanet_79211","EFO_0008583","EFO_0000319","EFO_1001486","MONDO_0005148","Orphanet_157"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 6 investigational indications."}
{"id":"CHEMBL29","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"JGSARLDLIJGVTE-MBNYWOFBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BENZYLPENICILLIN","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crystapen g"],"synonyms":["Benzyl penicillin","Benzylpenicillin","Benzylpenicillin ","Bicillin","J01CE01","NSC-193396","Penicillin G","Penicillin g","Penicillin-2","Permapen","Pfizerpen-AS"],"crossReferences":{"DailyMed":["penicillin%20g%20benzathine","penicillin%20g%20potassium","penicillin%20g%20sodium"],"PubChem":["49647119"],"Wikipedia":["Benzylpenicillin"],"drugbank":["DB01053"],"chEBI":["18208"]},"childChemblIds":["CHEMBL2105364","CHEMBL3989515","CHEMBL2107679","CHEMBL3182097","CHEMBL1126","CHEMBL1200651","CHEMBL1223"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and has 3 approved and 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3393066","canonicalSmiles":"Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C","inchiKey":"QYBGBLQCOOISAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3393066","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12986"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3402567","canonicalSmiles":"COc1c(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O.Cl","inchiKey":"ICIJBYYMEBOTQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITX-5061","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1208829","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ITX 5061","Itx 5061","Itx-5061","KC-706","KC706"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544964","canonicalSmiles":"Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1","inchiKey":"RZUOCXOYPYGSKL-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAVOXERTINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0994","GDC0994","Gdc-0994","RG-7842","Ravoxertinib"],"crossReferences":{"drugbank":["DB15281"]},"childChemblIds":["CHEMBL4581802"],"linkedTargets":{"rows":["ENSG00000102882","ENSG00000100030"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545157","canonicalSmiles":"O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1","inchiKey":"PMJIHLSCWIDGMD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIDEGLUSIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zentylor nypta"],"synonyms":["NP-031112","NP-12","NP031112","Np-031112","Tideglusib"],"crossReferences":{"drugbank":["DB12129"]},"linkedTargets":{"rows":["ENSG00000082701"],"count":1},"linkedDiseases":{"rows":["EFO_0003756","Orphanet_206647","MONDO_0004975","MONDO_0004976"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545311","canonicalSmiles":"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1","inchiKey":"AILRADAXUVEEIR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIGATINIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alunbrig"],"synonyms":["AP-26113","AP26113","Ap-26113","Brigatinib"],"crossReferences":{"DailyMed":["brigatinib"],"drugbank":["DB12267"]},"linkedTargets":{"rows":["ENSG00000146648","ENSG00000171094"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003032","MONDO_0024880","EFO_0003060"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for non-small cell lung carcinoma and neoplasm and has 1 investigational indication."}
{"id":"CHEMBL3577885","canonicalSmiles":"C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1","inchiKey":"BXNMZRPTQFVRFA-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05105679","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF 5105679","Pf-05105679"],"crossReferences":{"drugbank":["DB15450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3786673","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)NCCNC(=O)c1ccccc1O","inchiKey":"JQLBBYLGWHUHRW-KUBAVDMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDASALONEXENT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAT 1004","CAT-1004","Cat 1004","Cat-1004","Edasalonexent"],"crossReferences":{"drugbank":["DB15010"]},"linkedTargets":{"rows":["ENSG00000173039","ENSG00000109320","ENSG00000077150"],"count":3},"linkedDiseases":{"rows":["Orphanet_98896","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3833391","canonicalSmiles":"CCCCC1C(=O)N(C)N(C)C1=O.CCN(CC)CCNC(=O)COc1ccc(Cl)cc1.O.O","inchiKey":"JNHZIFUHHHJTFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFEZONE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3833413","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANP 3260","ANP-3260","Clofezone","Clofezone dihydrate"],"crossReferences":{"DrugCentral":["4335"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3833402","canonicalSmiles":"O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].[Al+3].[Al+3]","inchiKey":"DIZPMCHEQGEION-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM SULFATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aluminum sulfate"],"crossReferences":{"drugbank":["DB11239"]},"childChemblIds":["CHEMBL3833332"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3833405","canonicalSmiles":"CC(O)CN(C)C.CC(O)CN(C)C.CC(O)CN(C)C.O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"JBVWKTQYMFTKMW-MSQVLRTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INOSINE PRANOBEX","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3833327"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for viral disease and has 1 investigational indication."}
{"id":"CHEMBL395336","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@H]3[C@H]2O)c(=O)[nH]1","inchiKey":"ZOOGRGPOEVQQDX-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"cyclic GMP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["cyclic GMP"],"crossReferences":{"Wikipedia":["Cyclic_guanosine_monophosphate"],"drugbank":["DB02315"],"chEBI":["16356"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989426","drugType":"Small molecule","blackBoxWarning":false,"name":"CALAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cala soothe","Christie george's","Eczederm"],"synonyms":["Calamine"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3989950","canonicalSmiles":"CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)O)C(C)C","inchiKey":"VRNHFZYMPDKTBS-WYUJEMNCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RELTECIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB103","Reltecimod"],"childChemblIds":["CHEMBL3989963"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL402548","canonicalSmiles":"CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1","inchiKey":"XKFTZKGMDDZMJI-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANUSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danusertib","PHA-739358","Pha-739358"],"crossReferences":{"drugbank":["DB11778"]},"childChemblIds":["CHEMBL534499"],"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000565","EFO_0001378","MONDO_0008315"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL405","canonicalSmiles":"CC(N)Cc1ccccc1","inchiKey":"KWTSXDURSIMDCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMPHETAMINE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adzenys er","Adzenys xr-odt","Dyanavel xr"],"synonyms":["Amfetamin","Amfetamine","Amphetamine","Amphetamine resin complex","Amphetamine, dl-","Dyanavel","NSC-27159","Norephedrane"],"crossReferences":{"DailyMed":["amphetamine","amphetamine%20aspartate","amphetamine%20sulfate"],"Wikipedia":["Adderall","Amphetamine"],"drugbank":["DB00182"],"chEBI":["2679"]},"childChemblIds":["CHEMBL3250774","CHEMBL1200377","CHEMBL3250773","CHEMBL3250775","CHEMBL554211","CHEMBL1200387","CHEMBL3250772","CHEMBL3250770","CHEMBL3250771","CHEMBL501"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","EFO_0002610","MONDO_0002009","MONDO_0016158","EFO_0010445"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for attention deficit hyperactivity disorder and narcolepsy-cataplexy syndrome and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4069704","canonicalSmiles":"CCOC(=O)[C@@H]1CC2(CCN(c3cc(O[C@H](c4ccc(Cl)cc4-c4ccccc4)C(F)(F)F)nc(N)n3)CC2)CN1","inchiKey":"TZSZZENYCISATO-WIOPSUGQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RODATRISTAT ETHYL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KAR-5585","KAR5585","Rodatristat ethyl"],"linkedTargets":{"rows":["ENSG00000129167"],"count":1},"linkedDiseases":{"rows":["EFO_0001361"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL408513","canonicalSmiles":"O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO","inchiKey":"NCNRHFGMJRPRSK-MDZDMXLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELINOSTAT","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beleodaq"],"synonyms":["Belinostat","NSC726630","PX-105684","PXD-101","PXD101"],"crossReferences":{"DailyMed":["belinostat"],"Wikipedia":["Belinostat"],"drugbank":["DB05015"],"chEBI":["61076"]},"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000068024","ENSG00000147099","ENSG00000100429","ENSG00000116478","ENSG00000163517","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["MONDO_0019471","EFO_0002913","EFO_1000131","MONDO_0004222","EFO_1001469","EFO_0005952","MONDO_0002087","EFO_0000228","EFO_1000357","EFO_0000309","MONDO_0002158","EFO_1000043","MONDO_0015760","EFO_0000588","EFO_0000182","EFO_0000183","EFO_1001963","MONDO_0000430","EFO_0000198","EFO_0000616","EFO_1000616","MONDO_0019465","EFO_0000466","EFO_0001642","MONDO_0019457","EFO_0000403","EFO_0000222","EFO_0000313","EFO_1001968","EFO_0003060","EFO_0000311","EFO_0000211","EFO_1000576","EFO_0000304","EFO_1000581","EFO_0003032","EFO_0010832","EFO_0000702","EFO_0000574","EFO_1001051","MONDO_0018906","EFO_0001378","EFO_0000519"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 5 approved and 30 investigational indications."}
{"id":"CHEMBL42161","canonicalSmiles":"COCC(O)Cn1ccnc1[N+](=O)[O-]","inchiKey":"OBBCSXFCDPPXOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MISONIDAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Misonidazole","NSC-261,037","NSC-261037","RO 07-0582","RO 7-0582","RO-07-0582","RO-7-0582","RO-70582"],"crossReferences":{"PubChem":["139075","99360758"],"Wikipedia":["Misonidazole"],"drugbank":["DB11716"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4218271","canonicalSmiles":"C[C@H](N)C(=O)N1C[C@H](CCCB(O)O)[C@](N)(C(=O)O)C1","inchiKey":"ZZJLMZYUGLJBSO-LAEOZQHASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NUMIDARGISTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arginase inhibitor incb001158","CB-1158","Cb-1158","INCB-001158","INCB001158","Incb 001158","Incb001158","Numidargistat"],"crossReferences":{"drugbank":["DB15286"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297478","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nnc2ccccn12","inchiKey":"SLIVDYMORZGPLW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-114","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-114","Pf-114"],"crossReferences":{"drugbank":["DB15396"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297524","canonicalSmiles":"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cnccn5)n4)c3)cc(C(F)(F)F)c2)cn1","inchiKey":"DUPWHXBITIZIKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IY5511","Radotinib"],"crossReferences":{"drugbank":["DB12323"]},"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716"],"count":2},"linkedDiseases":{"rows":["EFO_0000339","MONDO_0005180"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297787","drugType":"Antibody","blackBoxWarning":false,"name":"MONALIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPH-2201 (ANTI-NKG2A)","IPH2201","Iph-2201","Iph2201","Monalizumab","NN-8765","NN8765","NN8765-3658"],"linkedTargets":{"rows":["ENSG00000134545"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0100096","EFO_0000095","MONDO_0021148","EFO_0004284","MONDO_0007254","EFO_0000199","EFO_0000707","EFO_0000181","EFO_0003060","EFO_0000311"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL4297926","drugType":"Unknown","blackBoxWarning":false,"name":"CJM-112","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CJM-112","CJM112","Cjm-112","Cjm112"],"linkedTargets":{"rows":["ENSG00000112115"],"count":1},"linkedDiseases":{"rows":["EFO_1000710","EFO_0000676","MONDO_0004979","EFO_0001378","EFO_0003894"],"count":5},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298043","canonicalSmiles":"Cl.O.O.O=C(CN1CCC(CN2Cc3ccccc3C2=O)CC1)c1ccc(F)cc1","inchiKey":"NZKANSJXJCILHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLUPERIDONE HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4297605","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYR-101","CYR-101 HYDROCHLORIDE DIHYDRATE","MIN-101","MT-210","Min-101","Roluperidone hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298084","drugType":"Antibody","blackBoxWarning":false,"name":"ODRONEXTAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Odronextamab","REGN-1979","REGN1979","Regn-1979","Regn1979"],"linkedTargets":{"rows":["ENSG00000160654","ENSG00000167286","ENSG00000198851","ENSG00000156738"],"count":4},"linkedDiseases":{"rows":["EFO_0000096","EFO_0000095","EFO_0000574"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL433","canonicalSmiles":"CCCC(CCC)C(=O)[O-].[Na+]","inchiKey":"AEQFSUDEHCCHBT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"VALPROATE SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL109","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Delepsine","Depacon","Depakine","Depakote","Depakote CP","Depakote ER","Epilim","Epilim 200","Epilim 500","Epilim chrono 200","Epilim chrono 300","Epilim chrono 500","Epilim chronosphere","Epilim iv","Episenta","Kentilim","Orfiril","Orlept","Valproate sodium"],"synonyms":["A-44090","ABBOTT 44090","ABBOTT-44090","KW-6066N","NSC-732626","NSC-757376","Natrii valproas","Selenica","Sodium 2-propylpentanoate","Sodium valproate","Valproate sodium","Valproic acid sodium salt (1:1)","Valproic acid, sodium","Valproic acid, sodium salt"],"crossReferences":{"DailyMed":["valproate%20sodium"],"PubChem":["11112073","144212940","50106736","50112990","57264447","85231324"],"Wikipedia":["Sodium_valproate"],"chEBI":["9925"]},"linkedTargets":{"rows":["ENSG00000112294"],"count":1},"linkedDiseases":{"rows":["EFO_0008525","MONDO_0005090","MONDO_0005277","EFO_0000289","EFO_0000474","EFO_0009430","MONDO_0004976","MONDO_0007079","MONDO_0003478","EFO_0005762","EFO_0003888","EFO_0008526","EFO_0000198","EFO_0000403","EFO_0003758","EFO_0009963","HP_0001250","Orphanet_783","HP_0000713","Orphanet_368","EFO_0004192","EFO_0005800","EFO_0000095","MONDO_0004975","MONDO_0004979","EFO_0005611","MONDO_0043510","Orphanet_3463","EFO_0000519"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for epilepsy and has 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL451509","canonicalSmiles":"CCCCC/C=C\\C/C=C\\C=C\\C=C\\[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O","inchiKey":"GWNVDXQDILPJIG-NXOLIXFESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL451509","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756768"],"drugbank":["DB08855"],"chEBI":["16978"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL453137","canonicalSmiles":"Cc1cc(C(=O)Nc2cc(Br)c(O)c(Br)c2)cc(C)c1O","inchiKey":"HHFKUQZPNITQLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL453137","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07695"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594328","drugType":"Gene","blackBoxWarning":false,"name":"BEREMAGENE GEPERPAVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beremagene geperpavec","KB-103","KB103"],"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650359","canonicalSmiles":"C=C1C(=O)O[C@@H]2/C=C(\\C)C[C@H]3C=C(CC/C=C(\\C)CC[C@@H]12)C(=O)O3","inchiKey":"KTYZKXFERQUCPX-SIKGVNBJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OVATODIOLIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-100 (OV)","AR100","AR100DP1","Ar-100dp1","Ar100dp1","NSC-156130","NSC-272353","Ovatodiolide"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650379","drugType":"Antibody","blackBoxWarning":false,"name":"BAMLANIVIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bamlanivimab","LY-3819253","LY-CoV555","LY3819253","Ly3819253"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650429","drugType":"Unknown","blackBoxWarning":false,"name":"TOZINAMERAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BNT-162B2","BNT162B2","Bnt162b2","Comirnaty","Pfizer covid-19 vaccine","Rna ingredient bnt-162b2","Tozinameran"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL468837","canonicalSmiles":"CCC1(C2=CCCCCC2)C(=O)NC(=O)NC1=O","inchiKey":"PAZQYDJGLKSCSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTABARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Heptabarb","Heptabarbital","Heptabarbitone"],"crossReferences":{"Wikipedia":["Heptabarb"],"drugbank":["DB01354"],"chEBI":["81297"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL475534","canonicalSmiles":"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1","inchiKey":"PVHUJELLJLJGLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITRENDIPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baypress"],"synonyms":["BAY E 5009","BAY-E-5009","Bayotensin","Deiten","NSC-758466","Nidrel","Nitrendipine","Nitrepin"],"crossReferences":{"PubChem":["104171193","124880808","144203752","170465897","26751794","26751795","50104488","85231144","90341570"],"Wikipedia":["Nitrendipine"],"drugbank":["DB01054"],"chEBI":["7582"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL4802131","canonicalSmiles":"CS(=O)(=O)O.CS(=O)(=O)O.Cc1c(F)c(N)c2c(=O)cc(-c3ccc(NC(=O)[C@@H](N)CCCCCCN)c(F)c3)oc2c1F","inchiKey":"FGBVBMVABCVDKQ-CKUXDGONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFP-464","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4804171","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AFP464","Afp 464","Afp-464","Afp464"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL483158","canonicalSmiles":"COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O","inchiKey":"ZLHFILGSQDJULK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALISERTIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alisertib","MLN 8237","MLN-8237","MLN8237","Mln-8237"],"crossReferences":{"PubChem":["103905632","137276087","174006392"],"drugbank":["DB05220"]},"childChemblIds":["CHEMBL2103871","CHEMBL3586471"],"linkedTargets":{"rows":["ENSG00000087586"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0006859","EFO_0001075","EFO_0000403","MONDO_0007254","EFO_0000222","EFO_1001469","MONDO_0002087","EFO_0000305","EFO_0000621","EFO_0003060","EFO_0000311","EFO_0000211","EFO_0000309","MONDO_0002158","EFO_1001974","MONDO_0008903","EFO_0000673","EFO_1002008","EFO_0000574","EFO_0006544","EFO_0001378","EFO_0000702","MONDO_0018906","MONDO_0002516","EFO_0000181"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 24 investigational indications."}
{"id":"CHEMBL484780","canonicalSmiles":"C/C(O)=C(\\C#N)C(=O)Nc1ccc(-c2ccccc2Cl)c(Cl)c1","inchiKey":"DDSLONVJHZPSBB-UVTDQMKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL484780","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07559"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL494","canonicalSmiles":"CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O","inchiKey":"HIFJCPQKFCZDDL-ACWOEMLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILOPROST","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ventavis"],"synonyms":["Ciloprost","Endoprost","Ilomedin","Iloprost","ZK 00036374","ZK-00036374","ZK-36374"],"crossReferences":{"DailyMed":["iloprost"],"drugbank":["DB01088"],"chEBI":["63916"]},"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0003943","MONDO_0005149","EFO_0001361","EFO_0006834","MONDO_0100130","EFO_0001071","EFO_1001145","EFO_0000537","EFO_0003144","MONDO_0008903","EFO_0003884","MONDO_0004979","EFO_1001373","EFO_0000341","HP_0004419","EFO_0000612","EFO_0000717","EFO_0009492","EFO_0004265"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 3 approved and 13 investigational indications."}
{"id":"CHEMBL498672","canonicalSmiles":"C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)c(C(=O)O)c1O","inchiKey":"WVOLTBSCXRRQFR-DLBZAZTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANNABIDIOL ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cannabidiol acid"],"crossReferences":{"chEBI":["3359"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL609980","canonicalSmiles":"NCCO[N+](=O)[O-]","inchiKey":"KZTZJUQNSSLNAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOETHYL NITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminoethyl nitrate","Itramin","Nitroethanolamine"],"crossReferences":{"drugbank":["DB13585"]},"childChemblIds":["CHEMBL2106780"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL65067","canonicalSmiles":"O=C(C(c1ccccc1)c1ccccc1)N1CCN(CC(O)COc2cccc3ncccc23)CC1","inchiKey":"KLWUUPVJTLHYIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOFEQUIDAR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dofequidar"],"crossReferences":{"drugbank":["DB14067"]},"childChemblIds":["CHEMBL3116252"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL690","canonicalSmiles":"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+]","inchiKey":"VWBQYTRBTXKKOG-IYNICTALSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAVASTATIN SODIUM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1144","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elisor","Lipemol","Liplat","Lipostat","Pravachol","Pravastatin sodium"],"synonyms":["CS-514","Dehypotin protect","Eptastatin sodium","NSC-759253","Pravastatin sodium","SQ-31,000","SQ-31000"],"crossReferences":{"DailyMed":["pravastatin%20sodium"],"PubChem":["144205027","144210590","26753280"],"chEBI":["8361"]},"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["HP_0002140","HP_0003124","EFO_0001645","EFO_0000180","EFO_0000319","EFO_1000727","EFO_0004911","EFO_0000537","EFO_0003913","EFO_0000565","MONDO_0002691","EFO_0003914","EFO_0003854","MONDO_0021661","MONDO_0005147","MONDO_0008903","Orphanet_79211","EFO_0004255","EFO_0000764","EFO_0000612","EFO_0003918","MONDO_0005148","EFO_0000400","EFO_0005672","EFO_0004705"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 10 approved and 9 investigational indications."}
{"id":"CHEMBL8224","canonicalSmiles":"CCc1cc(OC)c(CC(C)N)cc1OC","inchiKey":"HXJKWPGVENNMCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL8224","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["2,5-Dimethoxy-4-ethylamphetamine"],"drugbank":["DB01467"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL83088","canonicalSmiles":"Nc1cc2ccccc2c2ccccc12","inchiKey":"KIHQWOBUUIPWAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Phenanthren-9-Ylamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenanthren-9-Ylamine"],"crossReferences":{"drugbank":["DB03369"],"chEBI":["50475"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL867","canonicalSmiles":"CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O","inchiKey":"OIRFJRBSRORBCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOPANOIC ACID","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Telepaque"],"synonyms":["Acidum iopanoicum","Bilijodon","Choladine","Cholevid","Cistobil","Colepax","Copanoic","Iodopanoic acid","Iopagnost","Iopanoate","Iopanoic Acid","Iopanoic acid","Jopagnost","Jopanoic acid","NSC-41706"],"crossReferences":{"PubChem":["144203945","144213787","170465056","26748863","56463181"],"Wikipedia":["Iopanoic_acid"],"drugbank":["DB08946"],"chEBI":["5951"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951."}
